Morgan E. Obrien - Mar 13, 2023 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Executive Chairman, Director
Signature
/s/ Gena Ashe, attorney-in-fact
Stock symbol
ATEX
Transactions as of
Mar 13, 2023
Transactions value $
-$496,973
Form type
4
Date filed
3/15/2023, 06:04 PM
Previous filing
Dec 6, 2022
Next filing
May 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Options Exercise $400K +20K +62.6% $20.00 51.9K Mar 13, 2023 Direct
transaction ATEX Common Stock Options Exercise $455K +20K +38.5% $22.75 71.9K Mar 13, 2023 Direct
transaction ATEX Common Stock Sale -$151K -5K -6.95% $30.29 66.9K Mar 13, 2023 Direct F1
transaction ATEX Common Stock Sale -$1.2M -40K -59.75% $30.01 26.9K Mar 13, 2023 Direct F2
transaction ATEX Common Stock Gift $0 -1K -3.71% $0.00 25.9K Oct 12, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Options Exercise $0 -20K -100% $0.00* 0 Mar 13, 2023 Common Stock 20K $20.00 Direct F4
transaction ATEX Stock Option (Right to Buy) Options Exercise $0 -20K -36.4% $0.00 34.9K Mar 13, 2023 Common Stock 20K $22.75 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.79 to $30.56. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.77 to $30.28. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 These transactions represent a charitable contribution by the Reporting Person.
F4 The option shares are fully vested.